Meristem Family Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.11M Sell
3,886
-598
-13% -$154K 0.12% 96
2021
Q4
$1.24M Buy
4,484
+148
+3% +$37.5K 0.11% 109
2021
Q3
$1M Buy
+4,336
New +$1.07M 0.1% 132
2020
Q3
Sell
-3,410
Closed -$560K 206
2020
Q2
$560K Buy
3,410
+47
+1% +$7.21K 0.15% 85
2020
Q1
$467K Sell
3,363
-45
-1% -$6.18K 0.14% 93
2019
Q4
$448K Sell
3,408
-350
-9% -$40.6K 0.11% 111
2019
Q3
$420K Buy
+3,758
New +$418K 0.11% 112
2013
Q4
Sell
-4,010
Closed -$202K 116
2013
Q3
$202K Buy
+4,010
New +$210K 0.09% 106

Other funds holding LLY

Meristem Family Wealth's LLY Position: Q1 2022 in Review

Meristem Family Wealth reduced its Eli Lilly (LLY) stake by 13% in Q1 2022, selling an estimated $154K and leaving 3,886 shares worth $1.11M. The position accounts for 0.12% of the portfolio, ranked #96.

Meristem Family Wealth first reported a position in LLY in Q3 2013 and has held it in 8 quarters since. The position peaked at $1.24M in Q4 2021. 2,346 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Meristem Family Wealth held 3,886 shares of Eli Lilly worth $1.11M as of Q1 2022.
  • Meristem Family Wealth sold 598 Eli Lilly shares in Q1 2022, an estimated $154K.
  • Eli Lilly made up 0.12% of Meristem Family Wealth's portfolio in Q1 2022, its #96 holding.
  • Meristem Family Wealth first reported a position in Eli Lilly in Q3 2013 and has held it in 8 quarters since.
  • Meristem Family Wealth's Eli Lilly position peaked at $1.24M in Q4 2021.
  • 2,346 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Meristem Family Wealth's 13F filing for Q1 2022, filed 11 May 2022.